The latest closing stock price for Cullinan Therapeutics as of March 03, 2025 is 8.00.
An investor who bought $1,000 worth of Cullinan Therapeutics stock at the IPO in 2021 would have $-733 today, roughly -1 times their original investment - a -28.09% compound annual growth rate over 4 years.
The all-time high Cullinan Therapeutics stock closing price was 53.42 on March 10, 2021.
The Cullinan Therapeutics 52-week high stock price is 30.19, which is 277.4% above the current share price.
The Cullinan Therapeutics 52-week low stock price is 7.95, which is 0.6% below the current share price.
The average Cullinan Therapeutics stock price for the last 52 weeks is 16.47.
An investor who bought $1,000 worth of Cullinan Therapeutics stock at the IPO in 2021 would have $-733 today, roughly -1 times their original investment - a -28.09% compound annual growth rate over 4 years.
The all-time high Cullinan Therapeutics stock closing price was 53.42 on March 10, 2021.
The Cullinan Therapeutics 52-week high stock price is 30.19, which is 277.4% above the current share price.
The Cullinan Therapeutics 52-week low stock price is 7.95, which is 0.6% below the current share price.
The average Cullinan Therapeutics stock price for the last 52 weeks is 16.47.